Commissariat au lobbying du Canada Commissariat au lobbying du Canada

Sélection de la langue

Le Registre des lobbyistes

Sommaire de 12 mois d'activités de lobbying - Lobbyistes salariés d'entreprises

Retour aux résultats de la recherche de 12 mois d'activités de lobbying

AstraZeneca Canada Inc. / Gaby Bourbara, President

Retour aux résultats de la recherche de 12 mois d'activités de lobbying

Adresse et activités de l'entreprise

AstraZeneca Canada Inc. - Adresse et activités de l'entreprise

Adresse :

1004 Middlegate Road, Suite 5000
Mississauga, ON  L4Y 1M4
Canada

Numéro de téléphone : 800-565-5877

  • Coordonnées dans les versions précédentes
    • 1004 Middlegate Road, Suite 5000
      Mississauga, ON  L4Y 1M4
      Canada

      Numéro de téléphone : 800-565-5877  Poste 44826

    • 1004 Middlegate Road
      Mississauga, ON  L4Y 1M4
      Canada

      Numéro de téléphone : 905-804-5840

    • 1004 Middlegate Road
      Mississauga, ON  L4Y 1M4
      Canada

      Numéro de téléphone : 905-277-7111  Poste 46448

    • 1004 Middlegate Road
      Mississauga, ON  L4Y 1M4
      Canada

      Numéro de téléphone : 905-615-6883

    • 1004 Middlegate Road
      Mississauga, ON  L4Y 1M4
      Canada

      Numéro de téléphone : 905-566-7323

    • 1004 Middlegate Road
      Mississauga, ON  L4Y 1M4
      Canada

      Numéro de téléphone : 905-566-7323

      Numéro de fax :  


Description des activités :
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca’s Canadian headquarters are located in Mississauga, Ontario. For more information, please visit the company’s website at www.astrazeneca.ca.

  • Descriptions des activités de l'entreprise dans les versions précédentes :
    • AstraZeneca is the largest research-based pharmaceutical company in Canada and one of the largest pharmaceutical companies in the world. Defined by the belief that "Health Connects Us All," AstraZeneca is a company that is focused on making a meaningful difference to patients' lives through collaborations. In Canada, we invest approximately $100 million annually in research and development and charitable donations. The company employs approximately 850 people across Canada who strive to make the most meaningful difference to patient health through the discovery, development and marketing of our great medicines. Most of our Canadian employees work at our high-tech headquarters in Mississauga, Ontario, while 125 highly-skilled scientists work at our world-class basic pain research centre in Montréal, Québec. AstraZeneca Research & Development Montréal (AZRDM) is a leader in pain control research, and scientists at the facility are focused on finding new and innovative therapeutic solutions to treat acute and chronic pain. Our innovative and extensive product portfolio focuses on six key areas of medicine: gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease.
    • AstraZeneca is one of the largest pharmaceutical companies in the world and is the 2nd largest research-based pharmaceutical company in Canada. Our unique combination of curiosity and a fundamental commitment to patient health are the key drivers of research and development. Looking beyond the obvious and solving problems innovatively enables our scientists and the researchers we support to discover new and better treatments for a wide array of medical conditions and diseases. In Canada, we invest approximately $100 million annually in research and development initiatives. Most of our 1,050 Canadian employees work at our high-tech headquarters in Mississauga, Ontario, while over 120 scientists work at our world-class basic pain research centre in Montréal, Québec. AstraZeneca Research & Development Montréal (AZRDM) is a leader in pain control research, focusing primarily on the mechanisms involved in inflammatory and neuropathic pain, the two most common types of chronic pain. Our innovative and extensive product portfolio focuses on six areas of medicine: Cancer, Cardiovascular disease, Infection, Gastrointestinal disease, Neurological disorders, Respiratory and inflammatory conditions.
    • AstraZeneca Canada is the 2nd largest research-based pharmaceutical company in Canada. Our unique combination of curiosity and a fundamental commitment to patient health are the key drivers of research and development. Looking beyond the obvious and solving problems innovatively enables our scientists and the researchers we support to discover new and better treatments for a wide array of medical conditions and diseases. In Canada, we invest approximately $100 million annually in research and development initiatives. Most of our 1,000 Canadian employees work at our high-tech headquarters in Mississauga, Ontario. Over 125 scientists work at our world-class basic pain research centre in Montréal, Québec. AstraZeneca Research & Development Montréal (AZRDM) is a leader in pain control research, focusing primarily on the mechanisms involved in inflammatory and neuropathic pain, the two most common types of chronic pain. Our innovative and extensive product portfolio focuses on six areas of medicine: Cancer, Cardiovascular disease, Infection, Gastrointestinal disease, Neurological disorders, Respiratory and inflammatory conditions.
    • AstraZeneca Canada is the 2nd largest research-based pharmaceutical company in Canada. Our unique combination of curiosity and a fundamental commitment to patient health are the key drivers of research and development. Looking beyond the obvious and solving problems innovatively enables our scientists and the researchers we support to discover new and better treatments for a wide array of medical conditions and diseases. In Canada, we invest over CDN$2 million each and every week on research initiatives. Most of our 1,050 Canadian employees work at our high-tech facility in Mississauga, Ontario, headquarters for packaging, clinical research, sales and marketing, and distribution. Over 125 scientists work at our world-class basic pain research centre in Montréal, Québec. AstraZeneca Research & Development Montréal (AZRDM) is a leader in pain control research, focusing primarily on the mechanisms involved in inflammatory and neuropathic pain, the two most common types of chronic pain. Our innovative and extensive product portfolio spans six therapeutic areas: cardiovascular, gastrointestinal, oncology, respiratory, neuroscience and infection.
    • AstraZeneca Canada is the 2nd largest research-based pharmaceutical company in Canada. Our unique combination of curiosity and a fundamental commitment to patient health are the key drivers of research and development. Looking beyond the obvious and solving problems innovatively enables our scientists and the researchers we support to discover new and better treatments for a wide array of medical conditions and diseases. In Canada, we invest over CDN$2 million each and every week on research initiatives. Most of our 1,400 Canadian employees work at our high-tech facility in Mississauga, Ontario, headquarters for packaging, clinical research, sales and marketing, and distribution. Over 125 scientists work at our world-class basic pain research centre in Montréal, Québec. AstraZeneca Research & Development Montréal (AZRDM) is a leader in pain control research, focusing primarily on the mechanisms involved in inflammatory and neuropathic pain, the two most common types of chronic pain. Our innovative and extensive product portfolio spans six therapeutic areas: cardiovascular, gastrointestinal, oncology, respiratory, neuroscience and infection.
    • AstraZeneca Canada is the 2nd largest research-based pharmaceutical company in Canada. Our unique combination of curiosity and a fundamental commitment to patient health are the key drivers of research and development. Looking beyond the obvious and solving problems innovatively enables our scientists and the researchers we support to discover new and better treatments for a wide array of medical conditions and diseases. In Canada, we invest over CDN$2 million each and every week on research initiatives. Most of our 1,400 Canadian employees work at our high-tech facility in Mississauga, Ontario, headquarters for packaging, clinical research, sales and marketing, and distribution. Over 125 scientists work at our world-class basic pain research centre in Montréal, Québec (AZRDM), one of only three basic pain research facilities in Canada. AZRDM is a leader in pain control research, focusing primarily on the mechanisms involved in inflammatory and neuropathic pain, the two most common types of chronic pain. Our innovative and extensive product portfolio spans six therapeutic areas: cardiovascular, gastrointestinal, oncology, respiratory, neuroscience and infection.


Charges publiques occupées : Heather McDonald


Adresse

AstraZeneca PLC

1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge  CB20AA

Financement public

Aucun financement public n'a été reçu au cours du dernier exercice financier complet.
Date de la dernière version :